Jurisprudentia canonico-civilis seu Ius canonicum universum iuxta V libros decretalium nova et facili methodo explanatum ... /

Mode of access: Internet.

Collectanea doctorum tam veterum quam recentiorum, in ius pontificium uniuersum : tomus primus : in quo duo priores Decretalium libri continentur /

Mode of access: Internet.

Collectanea doctorum tam veterum quam recentiorum, in ius pontificium uniuersum : tomus secundus : in quo tertius & quartus Decretalium libri continentur /

Mode of access: Internet.

Notae historicae in universum ius canonicum rationibus consentaneis adsertae ... /

Mode of access: Internet.

Augustini Barbosae ... Summa apostolicarum decisionum extra ius commune vagantium ...

Mode of access: Internet.

BEITRAGE ZUR LEHRE VOM IUS GENTIUM DER ROMER

Mode of access: Internet.

Usual medical treatments or levonorgestrel-IUS for women with heavy menstrual bleeding:long-term randomised pragmatic trial in primary care

Background: Heavy menstrual bleeding (HMB) is a common, chronic problem affecting women and health services. However, long-term evidence on treatment in primary care is lacking. Aim: To assess the effectiveness of commencing the levonorgestrel-releasing intrauterine system (LNG-IUS) or usual medical treatments for women presenting with HMB in general practice. Design and setting: A pragmatic, multicentre, parallel, open-label, long term, randomised controlled trial in 63 primary care practices across the English Midlands. Method: In total, 571 women aged 25–50 years, with HMB were randomised to LNG-IUS or usual medical treatment (tranexamic/mefenamic acid, combined oestrogen–progestogen, or progesterone alone). The primary outcome was the patient reported Menorrhagia Multi-Attribute Scale (MMAS, measuring effect of HMB on practical difficulties, social life, psychological and physical health, and work and family life; scores from 0 to 100). Secondary outcomes included surgical intervention (endometrial ablation/hysterectomy), general quality of life, sexual activity, and safety. Results: At 5 years post-randomisation, 424 (74%) women provided data. While the difference between LNG-IUS and usual treatment groups was not significant (3.9 points; 95% confidence interval = −0.6 to 8.3; P = 0.09), MMAS scores improved significantly in both groups from baseline (mean increase, 44.9 and 43.4 points, respectively; P<0.001 for both comparisons). Rates of surgical intervention were low in both groups (surgery-free survival was 80% and 77%; hazard ratio 0.90; 95% CI = 0.62 to 1.31; P = 0.6). There was no difference in generic quality of life, sexual activity scores, or serious adverse events. Conclusion: Large improvements in symptom relief across both groups show treatment for HMB can be successfully initiated with long-term benefit and with only modest need for surgery.

Del ius puniendi: categorías dogmáticas que generan tensión entre el derecho penal y el derecho disciplinario

34 p.

Ricerche in materia di 'ius emphyteuticum' sulle 'meliorationes, quae graeco vocabulo emponemata dicuntur'

Le presenti ricerche indagano la disciplina delle «meliorationes, quae graeco vocabulo emponemata dicuntur» nell’ambito dell’enfiteusi privata giustinianea, pervenendo, a seguito della ricostruzione della nozione di «emponemata», a una interpretazione di C. 4.66.3 (a. 530) secondo la quale questa costituzione non implicherebbe – anche in ragione del confronto testuale con Nov. 64 (a. 538), in materia di «misthosis» – una deroga al principio «superficies solo cedit» e – con riferimento alla fattispecie della loro alienazione – farebbe del termine «meliorationes» un uso condizionale e metonimico, volto a enucleare – nell’ambito delle diverse possibilità di trasferimento «inter vivos» dell’enfiteusi – il caso (oggetto di speciale normazione) della «venditio» per la sola ipotesi in cui sul fondo enfiteutico fossero intervenute «meliorationes» tali da poter essere qualificate come «emponemata».

Reasons For Brazilian Women To Switch From Different Contraceptives To Long-acting Reversible Contraceptives.

Long-acting reversible contraceptives (LARCs) include the copper-releasing intrauterine device (IUD), the levonorgestrel-releasing intrauterine system (LNG-IUS) and implants. Despite the high contraceptive efficacy of LARCs, their prevalence of use remains low in many countries. The objective of this study was to assess the main reasons for switching from contraceptive methods requiring daily or monthly compliance to LARC methods within a Brazilian cohort. Women of 18-50 years of age using different contraceptives and wishing to switch to a LARC method answered a questionnaire regarding their motivations for switching from their current contraceptive. Continuation rates were evaluated 1 year after method initiation. Sample size was calculated at 1040 women. Clinical performance was evaluated by life table analysis. The cutoff date for analysis was May 23, 2013. Overall, 1167 women were interviewed; however, after 1 year of use, the medical records of only 1154 women were available for review. The main personal reason for switching, as reported by the women, was fear of becoming pregnant while the main medical reasons were nausea and vomiting and unscheduled bleeding. No pregnancies occurred during LARC use, and the main reasons for discontinuation were expulsion (in the case of the IUD and LNG-IUS) and a decision to undergo surgical sterilization (in the case of the etonogestrel-releasing implant). Continuation rate was ~95.0/100 women/year for the three methods. Most women chose a LARC method for its safety and for practical reasons, and after 1 year of use, most women continued with the method.